universal health services inc. - UHS
UHS
Close Chg Chg %
186.53 -0.32 -0.17%
Closed Market
186.22
-0.32 (0.17%)
Volume: 733.22K
Last Updated:
Mar 28, 2025, 3:59 PM EDT
Company Overview: universal health services inc. - UHS
UHS Key Data
| Open $187.15 | Day Range 185.64 - 188.38 |
| 52 Week Range 152.70 - 243.25 | Market Cap $12.12B |
| Shares Outstanding 65.00M | Public Float 54.14M |
| Beta 1.32 | Rev. Per Employee N/A |
| P/E Ratio 10.97 | EPS $17.17 |
| Yield 43.37% | Dividend $0.20 |
| EX-DIVIDEND DATE Mar 3, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.10M |
UHS Performance
| 1 Week | 6.91% | ||
| 1 Month | 6.24% | ||
| 3 Months | 3.17% | ||
| 1 Year | 2.04% | ||
| 5 Years | 109.21% |
UHS Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
21
Full Ratings ➔
About universal health services inc. - UHS
Universal Health Services, Inc. engages in providing hospital and healthcare services. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services, and Other. The Acute Care Hospital Services segment includes hospitals, freestanding emergency departments, and ambulatory centers. The Behavioral Health Care Services segment offers treatment programs for depression, anxiety, psychotic diagnoses, bipolar disorder, post-traumatic stress disorder, and neurorehabilitation. The Other segment consists of centralized services such as information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising, and design and construction. The company was founded by Alan B. Miller in 1979 and is headquartered in King of Prussia, PA.
UHS At a Glance
Universal Health Services, Inc.
Universal Corporate Center
King of Prussia, Pennsylvania 19406-3121
| Phone | 1-610-768-3300 | Revenue | 15.83B | |
| Industry | Hospital/Nursing Management | Net Income | 1.14B | |
| Sector | Health Services | 2024 Sales Growth | 10.825% | |
| Fiscal Year-end | 12 / 2025 | Employees | 99,000 | |
| View SEC Filings |
UHS Valuation
| P/E Current | 10.966 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 10.667 |
| Price to Sales Ratio | 0.77 |
| Price to Book Ratio | 1.749 |
| Price to Cash Flow Ratio | 5.893 |
| Enterprise Value to EBITDA | 7.548 |
| Enterprise Value to Sales | 1.081 |
| Total Debt to Enterprise Value | 0.29 |
UHS Efficiency
| Revenue/Employee | 159,878.131 |
| Income Per Employee | 11,535.828 |
| Receivables Turnover | 7.268 |
| Total Asset Turnover | 1.084 |
UHS Liquidity
| Current Ratio | 1.274 |
| Quick Ratio | 1.174 |
| Cash Ratio | 0.057 |
UHS Profitability
| Gross Margin | 10.626 |
| Operating Margin | 10.626 |
| Pretax Margin | 9.464 |
| Net Margin | 7.215 |
| Return on Assets | 7.819 |
| Return on Equity | 17.823 |
| Return on Total Capital | 9.827 |
| Return on Invested Capital | 10.007 |
UHS Capital Structure
| Total Debt to Total Equity | 74.337 |
| Total Debt to Total Capital | 42.64 |
| Total Debt to Total Assets | 33.361 |
| Long-Term Debt to Equity | 72.616 |
| Long-Term Debt to Total Capital | 41.653 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Universal Health Services Inc. - UHS
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 12.64B | 13.40B | 14.28B | 15.83B | |
Sales Growth
| +9.37% | +5.99% | +6.59% | +10.82% | |
Cost of Goods Sold (COGS) incl D&A
| 11.26B | 12.34B | 13.11B | 14.15B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 533.21M | 581.86M | 568.04M | 584.83M | |
Depreciation
| 501.60M | 544.00M | 535.60M | 559.60M | |
Amortization of Intangibles
| 31.61M | 37.86M | 32.44M | 25.23M | |
COGS Growth
| +10.42% | +9.53% | +6.23% | +7.93% | |
Gross Income
| 1.38B | 1.06B | 1.18B | 1.68B | |
Gross Income Growth
| +1.51% | -22.97% | +10.77% | +43.09% | |
Gross Profit Margin
| +10.90% | +7.92% | +8.23% | +10.63% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| - | - | - | - | - |
Research & Development
| - | - | - | - | - |
Other SG&A
| - | - | - | - | - |
SGA Growth
| - | - | - | - | - |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 31.22M | 57.55M | 45.75M | (62.34M) | |
EBIT after Unusual Expense
| 1.35B | 1.00B | 1.13B | 1.74B | |
Non Operating Income/Expense
| 32.32M | (10.03M) | 18.04M | (58.69M) | |
Non-Operating Interest Income
| 1.60M | 378.00K | 572.00K | 1.43M | |
Equity in Earnings of Affiliates
| 6.20M | 1.20M | 874.00K | 1.10M | |
Interest Expense
| 85.27M | 127.27M | 207.25M | 187.53M | |
Interest Expense Growth
| -21.84% | +49.26% | +62.84% | -9.51% | |
Gross Interest Expense
| 89.68M | 135.89M | 231.67M | 226.46M | |
Interest Capitalized
| 4.41M | 8.62M | 24.42M | 38.92M | |
Pretax Income
| 1.29B | 866.26M | 940.43M | 1.50B | |
Pretax Income Growth
| +3.29% | -33.02% | +8.56% | +59.28% | |
Pretax Margin
| +10.23% | +6.46% | +6.58% | +9.46% | |
Income Tax
| 305.68M | 209.28M | 221.12M | 334.83M | |
Income Tax - Current - Domestic
| 321.46M | 212.09M | 232.57M | 357.32M | |
Income Tax - Current - Foreign
| 13.75M | 14.74M | 6.50M | 10.96M | |
Income Tax - Deferred - Domestic
| (31.06M) | (16.04M) | (21.32M) | (32.14M) | |
Income Tax - Deferred - Foreign
| 1.52M | (1.51M) | 3.37M | (1.32M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| 6.20M | 1.20M | 874.00K | 1.10M | |
Other After Tax Income (Expense)
| (2.06M) | (748.00K) | (308.00K) | (50.00K) | |
Consolidated Net Income
| 985.57M | 656.23M | 719.00M | 1.16B | |
Minority Interest Expense
| (3.96M) | (18.63M) | 1.51M | 21.01M | |
Net Income
| 989.53M | 674.86M | 717.49M | 1.14B | |
Net Income Growth
| +5.16% | -31.80% | +6.32% | +59.17% | |
Net Margin Growth
| +7.83% | +5.04% | +5.02% | +7.22% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 989.53M | 674.86M | 717.49M | 1.14B | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 989.53M | 674.86M | 717.49M | 1.14B | |
EPS (Basic)
| 11.9916 | 9.2297 | 10.3502 | 17.1597 | |
EPS (Basic) Growth
| +8.06% | -23.03% | +12.14% | +65.79% | |
Basic Shares Outstanding
| 82.52M | 73.12M | 69.32M | 66.55M | |
EPS (Diluted)
| 11.8235 | 9.1405 | 10.2315 | 16.8205 | |
EPS (Diluted) Growth
| +7.20% | -22.69% | +11.94% | +64.40% | |
Diluted Shares Outstanding
| 83.69M | 73.83M | 70.13M | 67.90M | |
EBITDA
| 1.91B | 1.64B | 1.74B | 2.27B | |
EBITDA Growth
| +2.31% | -14.01% | +6.11% | +30.01% | |
EBITDA Margin
| +15.11% | +12.26% | +12.21% | +14.32% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 232.067 | |
| Number of Ratings | 21 | Current Quarters Estimate | 4.367 | |
| FY Report Date | 03 / 2025 | Current Year's Estimate | 19.214 | |
| Last Quarter’s Earnings | 4.92 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 16.61 | Next Fiscal Year Estimate | 21.319 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 16 | 16 | 18 | 16 |
| Mean Estimate | 4.37 | 5.04 | 19.21 | 21.32 |
| High Estimates | 4.74 | 5.74 | 21.30 | 22.36 |
| Low Estimate | 4.09 | 4.68 | 17.25 | 20.10 |
| Coefficient of Variance | 3.43 | 4.67 | 3.92 | 3.05 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 6 | 6 | 6 |
| OVERWEIGHT | 3 | 3 | 2 |
| HOLD | 12 | 11 | 11 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Universal Health Services Inc. - UHS
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Universal Health Services Inc. - UHS
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 24, 2025 | Matthew J. Peterson Executive Vice President, UHS | 16,324 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $178.7 per share | 2,917,098.80 |
| Mar 24, 2025 | Edward H. Sim Executive Vice President | 11,246 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $178.7 per share | 2,009,660.20 |
| Mar 24, 2025 | Marc Daniel Miller President and CEO; Director | 278,054 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $178.7 per share | 49,688,249.80 |
| Mar 24, 2025 | Alan B. Miller Executive Chairman; Director | 1,376,340 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $178.7 per share | 245,951,958.00 |
| Mar 24, 2025 | Steve G. Filton Executive Vice President & CFO | 118,501 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $178.7 per share | 21,176,128.70 |
| Mar 17, 2025 | Steve G. Filton Executive Vice President & CFO | 112,238 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.61 per share | 18,699,973.18 |
| Mar 17, 2025 | Marc Daniel Miller President and CEO; Director | 252,395 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.61 per share | 42,051,530.95 |
| Mar 17, 2025 | Matthew J. Peterson Executive Vice President, UHS | 11,185 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.61 per share | 1,863,532.85 |
| Mar 17, 2025 | Alan B. Miller Executive Chairman; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 17, 2025 | Alan B. Miller Executive Chairman; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 17, 2025 | Alan B. Miller Executive Chairman; Director | 1,363,399 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $163.99 per share | 223,583,802.01 |
| Mar 17, 2025 | Alan B. Miller Executive Chairman; Director | 1,508,326 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $67.69 per share | 102,098,586.94 |
| Mar 17, 2025 | Alan B. Miller Executive Chairman; Director | 1,411,659 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $74.46 per share | 105,112,129.14 |
| Mar 17, 2025 | Alan B. Miller Executive Chairman; Director | 1,293,726 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $166.61 per share | 215,547,688.86 |
| Mar 12, 2025 | Alan B. Miller Executive Chairman; Director | 96,667 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 12, 2025 | Maria Ruderman Singer Director | 10,879 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $67.69 per share | 736,399.51 |
| Mar 12, 2025 | Alan B. Miller Executive Chairman; Director | 117,933 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 12, 2025 | Marc Daniel Miller President and CEO; Director | 223,878 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $176.9 per share | 39,604,018.20 |
| Mar 12, 2025 | Marc Daniel Miller President and CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 12, 2025 | Marc Daniel Miller President and CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |